Sign In
Buy EDIT
$2.78
-0.0400 (-1.42%)
At Close: Jun 03, 2026
Bank of America Corp DE Sells 9,521 Shares of Editas Medicine Inc (NASDAQ:EDIT)
08:38am, Sunday, 26'th Apr 2020
Bank of America Corp DE lowered its holdings in shares of Editas Medicine Inc (NASDAQ:EDIT) by 26.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Com
Editas Medicine (NASDAQ:EDIT) vs. Rubius Therapeutics (NASDAQ:RUBY) Head-To-Head Comparison
05:56am, Saturday, 25'th Apr 2020
Editas Medicine (NASDAQ:EDIT) and Rubius Therapeutics (NASDAQ:RUBY) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of thei
Affinivax Announces $120 Million Series B Financing to Advance Pipeline of Novel MAPS Vaccines and Immunotherapies
11:00am, Thursday, 23'rd Apr 2020
Affinivax Announces $120 Million Series B Financing to Advance Pipeline of Novel MAPS Vaccines and Immunotherapies
We’re Hopeful That Editas Medicine (NASDAQ:EDIT) Will Use Its Cash Wisely
04:04pm, Tuesday, 21'st Apr 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Norges Bank Makes New Investment in Editas Medicine Inc (NASDAQ:EDIT)
09:38am, Saturday, 18'th Apr 2020
Norges Bank acquired a new position in shares of Editas Medicine Inc (NASDAQ:EDIT) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 682,259 shares of the
Exchange Traded Concepts LLC Acquires 1,812 Shares of Editas Medicine Inc (NASDAQ:EDIT)
09:30am, Thursday, 16'th Apr 2020
Exchange Traded Concepts LLC grew its holdings in shares of Editas Medicine Inc (NASDAQ:EDIT) by 117.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutiona
Alliancebernstein L.P. Has $2 Million Stake in Editas Medicine Inc (NASDAQ:EDIT)
08:06am, Thursday, 16'th Apr 2020
Alliancebernstein L.P. grew its holdings in shares of Editas Medicine Inc (NASDAQ:EDIT) by 1.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Excha
3 Stocks to Buy to Get a Big Bang for the Buck With Your Coronavirus Stimulus Check
11:07am, Wednesday, 15'th Apr 2020
These stocks should deliver explosive growth over the long run.
Geode Capital Management LLC Buys 67,536 Shares of Editas Medicine Inc (NASDAQ:EDIT)
10:20am, Wednesday, 15'th Apr 2020
Geode Capital Management LLC raised its stake in Editas Medicine Inc (NASDAQ:EDIT) by 10.5% during the 4th quarter, Holdings Channel reports. The fund owned 709,750 shares of the company’s stock aft
$5.95 Million in Sales Expected for Editas Medicine Inc (NASDAQ:EDIT) This Quarter
09:04am, Wednesday, 15'th Apr 2020
Brokerages expect Editas Medicine Inc (NASDAQ:EDIT) to post $5.95 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Ed
Coherus Biosciences (NASDAQ:CHRS) versus Editas Medicine (NASDAQ:EDIT) Head to Head Comparison
05:26am, Wednesday, 15'th Apr 2020
Coherus Biosciences (NASDAQ:CHRS) and Editas Medicine (NASDAQ:EDIT) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength
Cubist Systematic Strategies LLC Makes New Investment in Editas Medicine Inc (NASDAQ:EDIT)
09:29am, Tuesday, 14'th Apr 2020
Cubist Systematic Strategies LLC acquired a new position in Editas Medicine Inc (NASDAQ:EDIT) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Ex
Analysts Anticipate Editas Medicine Inc (NASDAQ:EDIT) Will Post Earnings of -$0.78 Per Share
11:20am, Monday, 13'th Apr 2020
Equities research analysts forecast that Editas Medicine Inc (NASDAQ:EDIT) will announce ($0.78) earnings per share for the current fiscal quarter, according to Zacks. Three analysts have provided est
Bank of New York Mellon Corp Has $7.69 Million Position in Editas Medicine Inc (NASDAQ:EDIT)
09:50am, Monday, 13'th Apr 2020
Bank of New York Mellon Corp grew its holdings in Editas Medicine Inc (NASDAQ:EDIT) by 3.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The ins
UBS Asset Management Americas Inc. Buys 1,327 Shares of Editas Medicine Inc (NASDAQ:EDIT)
10:36am, Sunday, 12'th Apr 2020
UBS Asset Management Americas Inc. grew its stake in Editas Medicine Inc (NASDAQ:EDIT) by 5.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 27,796 shares of the company’s stock
